Summary

Clinical drug trials are public goods and should be publicly funded to avoid undersupply, the suppression of adverse results and other problems, according to Tracy R. Lewis, Jerome H. Reichman and Anthony D. So.

Recommended Citation

Lewis, Tracy R.; Reichman, Jerome H.; and So, Anthony D. (2007) "The Case for Public Funding and Public Oversight of Clinical Trials," The Economists' Voice: Vol. 4 : Iss. 1, Article 3.
DOI: 10.2202/1553-3832.1123
Available at: http://www.bepress.com/ev/vol4/iss1/art3